ReposiTrak (NYSE:TRAK) Upgraded at Wall Street Zen

ReposiTrak (NYSE:TRAK) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

Separately, Weiss Ratings reiterated a “hold (c+)” rating on shares of ReposiTrak in a research note on Monday. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

ReposiTrak Trading Down 2.7%

Shares of ReposiTrak stock opened at $13.42 on Friday. The firm has a fifty day simple moving average of $14.39 and a 200-day simple moving average of $16.90. The stock has a market capitalization of $245.45 million, a price-to-earnings ratio of 37.28 and a beta of 0.39. ReposiTrak has a 1-year low of $12.75 and a 1-year high of $25.01.

ReposiTrak (NYSE:TRAK) last posted its earnings results on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter. The business had revenue of $5.97 million for the quarter. ReposiTrak had a net margin of 30.52% and a return on equity of 14.37%.

Insider Transactions at ReposiTrak

In other news, CEO Randall K. Fields sold 2,000 shares of the business’s stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $13.70, for a total transaction of $27,400.00. Following the transaction, the chief executive officer owned 182,500 shares in the company, valued at approximately $2,500,250. The trade was a 1.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last quarter, insiders have sold 89,500 shares of company stock valued at $1,340,230. Company insiders own 41.00% of the company’s stock.

Institutional Investors Weigh In On ReposiTrak

A number of institutional investors have recently added to or reduced their stakes in TRAK. BNP Paribas Financial Markets raised its holdings in ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after acquiring an additional 634 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after purchasing an additional 2,892 shares during the period. Copeland Capital Management LLC bought a new stake in shares of ReposiTrak during the third quarter valued at approximately $54,000. R Squared Ltd acquired a new position in shares of ReposiTrak in the second quarter valued at $235,000. Finally, GSA Capital Partners LLP bought a new position in ReposiTrak in the third quarter worth $219,000. 27.35% of the stock is owned by institutional investors and hedge funds.

About ReposiTrak

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.